DE69911955D1 - VERWENDUNG VON DANAZOL ZUR BEHANDLUNG VON HYPOGONADISMUS IN MÄNNERn - Google Patents

VERWENDUNG VON DANAZOL ZUR BEHANDLUNG VON HYPOGONADISMUS IN MÄNNERn

Info

Publication number
DE69911955D1
DE69911955D1 DE69911955T DE69911955T DE69911955D1 DE 69911955 D1 DE69911955 D1 DE 69911955D1 DE 69911955 T DE69911955 T DE 69911955T DE 69911955 T DE69911955 T DE 69911955T DE 69911955 D1 DE69911955 D1 DE 69911955D1
Authority
DE
Germany
Prior art keywords
ethisterone
danazole
men
male
hypogonadism
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69911955T
Other languages
English (en)
Other versions
DE69911955T2 (de
Inventor
Malcolm E Carruthers
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Multimed Ltd
Original Assignee
Multimed Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Multimed Ltd filed Critical Multimed Ltd
Publication of DE69911955D1 publication Critical patent/DE69911955D1/de
Application granted granted Critical
Publication of DE69911955T2 publication Critical patent/DE69911955T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Reproductive Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
DE69911955T 1998-04-09 1999-03-29 VERWENDUNG VON DANAZOL ZUR BEHANDLUNG VON HYPOGONADISMUS IN MÄNNERn Expired - Fee Related DE69911955T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9807809 1998-04-09
GBGB9807809.0A GB9807809D0 (en) 1998-04-09 1998-04-09 Compositions comprising ethisterone or its derivatives
PCT/GB1999/000984 WO1999052533A1 (en) 1998-04-09 1999-03-29 Compositions comprising ethisterone or its derivatives

Publications (2)

Publication Number Publication Date
DE69911955D1 true DE69911955D1 (de) 2003-11-13
DE69911955T2 DE69911955T2 (de) 2004-08-12

Family

ID=10830241

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69911955T Expired - Fee Related DE69911955T2 (de) 1998-04-09 1999-03-29 VERWENDUNG VON DANAZOL ZUR BEHANDLUNG VON HYPOGONADISMUS IN MÄNNERn

Country Status (8)

Country Link
EP (1) EP1079836B1 (de)
AT (1) ATE251460T1 (de)
AU (1) AU759767B2 (de)
DE (1) DE69911955T2 (de)
DK (1) DK1079836T3 (de)
ES (1) ES2212844T3 (de)
GB (1) GB9807809D0 (de)
WO (1) WO1999052533A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103169714A (zh) 2005-07-12 2013-06-26 Dmi生物科学公司 治疗疾病的方法和产品
DK2554173T3 (en) 2009-06-22 2017-01-16 Ampio Pharmaceuticals Inc PROCEDURE FOR DISEASE CARE
EA201500752A1 (ru) 2012-12-19 2016-05-31 Ампио Фармасьютикалс, Инк. Способ лечения заболеваний
CN107375910B (zh) * 2017-07-12 2020-03-24 温州医科大学附属第二医院、温州医科大学附属育英儿童医院 PTHrP在制备治疗男性性腺功能低下综合征中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5595970A (en) * 1993-07-16 1997-01-21 Schering Aktiengesellschaft Treatment of climacteric disorders with nitric oxide synthase substrates and/or donors
WO1997024148A1 (en) * 1995-12-29 1997-07-10 Cygnus, Inc. Systems and methods for the transdermal administration of androgenic agents
DE19619045C1 (de) * 1996-05-02 1997-11-13 Jenapharm Gmbh Verwendung von Kombinationspräparaten zur Behandlung hypogonadaler Männer sowie Männern mit Hypophysenerkrankungen

Also Published As

Publication number Publication date
ATE251460T1 (de) 2003-10-15
ES2212844T3 (es) 2004-08-01
EP1079836B1 (de) 2003-10-08
DK1079836T3 (da) 2004-02-16
AU3159899A (en) 1999-11-01
WO1999052533A1 (en) 1999-10-21
EP1079836A1 (de) 2001-03-07
GB9807809D0 (en) 1998-06-10
DE69911955T2 (de) 2004-08-12
AU759767B2 (en) 2003-05-01

Similar Documents

Publication Publication Date Title
DE60138553D1 (de) Pharmazeutische zusammensetzung und verfahren zur behandlung von hypogonadismus
ATE313326T1 (de) VERWENDUNG VON CABERGOLIN ZUR BEHANDLUNG VON ßRESTLESS LEGS SYNDROMß
ATE242632T1 (de) Verwendung von betulinsäure-derivaten zur behandlung und vorbeugung von melanomen
ATE279916T1 (de) Verwendung von substanzen, die die östrogen wirkung fördern, zur behandlung von wunden
CY1108563T1 (el) Μεθοδοι και υλικα για τη θεραπεια της ανεπαρκειας (ελλειψης) τεστοστερονης στους ανδρες
ATE305788T1 (de) (s,s)-reboxetin zur behandlung von inkontinenz
DE60015070D1 (de) Verwendung von antikonvulsiven derivaten zur behandlung der cluster headache
ATE383862T1 (de) Transdermale behandlung postklimakterischer frauen mit ultra-niedrigen estrogendosen
ATE251903T1 (de) Verwendung von phosphororganischen verbindungen zur therapeutischen und prophylaktischen behandlung von infektionen
DE60036169D1 (de) Methoden zur Behandlung der Hautpigmentierung
DE60013266D1 (de) Steroidnitrate zur behandlung von oxidativen schädigungen und endothelialer dysfunktion
DE60032795D1 (de) Nordihydroguaiaretinsäurederivate zur behandlung von tumoren
MXPA03005742A (es) Combinacion de un estrogeno y un androgeno para tratar deficiencias hormonales en mujeres que sufren terapia de reemplazo de estrogenos.
ATE415962T1 (de) Verwendung von asiatsäure oder asiaticosid zur behandlung von krebs
TR199901104T2 (xx) Farmas�tik bile�ikler.
ATE300295T1 (de) Verwendung von baclofen zur behandlung von alkoholismus
DE69018799D1 (de) IGF-I zur Behandlung von Nebeneffekten der Steroidtherapie.
DE69911955D1 (de) VERWENDUNG VON DANAZOL ZUR BEHANDLUNG VON HYPOGONADISMUS IN MÄNNERn
ATE253368T1 (de) Verwendung von bisphosphonaten zur prophylaxe und zur behandlung von infektiösen prozessen
DE59109225D1 (de) Verwendung von pyridylmethylsulfinyl-1h-benzimidazol derivaten zur behandlung durch helicobacter verursachter erkrankungen
DE60021252D1 (de) Antikonvulsiva zur behandlung von autismus
ATE250580T1 (de) Substituierte pyridino-arylpiperazine zur behandlung benigner prostatahyperplasie
DE69818809D1 (de) Verfahren zur behandlung von narbengewebe
ATE359808T1 (de) Verwendung von sarp-1 zur behandlung und/oder vorbeugung von scleroderma
ES2180345T3 (es) Nuevo procedimiento para la crio-conservacion de plantas.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee